{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:39:11Z","timestamp":1782319151203,"version":"3.54.5"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,2,1]]},"DOI":"10.2169\/internalmedicine.3112-23","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:12:30Z","timestamp":1720044750000},"page":"337-342","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease"],"prefix":"10.2169","volume":"64","author":[{"given":"Atsushi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Zeniya","sequence":"additional","affiliation":[{"name":"Akasaka Sanno Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Arinaga-Hino","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Takaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hon","family":"Kang","sequence":"additional","affiliation":[{"name":"Center for Gastroenterology, Teine Keijinkai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The Third Hospital of Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohamashi Tobu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of Japan Autoimmune Hepatitis Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158: 1999-2014.e1991, 2020.","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73: 202-209, 2020.","DOI":"10.1016\/j.jhep.2020.07.045"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsutsumi T, Eslam M, Kawaguchi T, et al. MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: generalized estimating equation approach. Hepatol Res 51: 1115-1128, 2021.","DOI":"10.1111\/hepr.13685"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lee H, Lee YH, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol 19: 2138-2147.e2110, 2021.","DOI":"10.1016\/j.cgh.2020.12.022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kemp W, Clayton-Chubb D, Majeed A, et al. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: results from a prospective population-based study. J Gastroenterol Hepatol 37: 395-403, 2022.","DOI":"10.1111\/jgh.15723"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol 75: 1284-1291, 2021.","DOI":"10.1016\/j.jhep.2021.07.035"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takahashi A, Ohira H, Abe K, et al. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep 10: 14250, 2020.","DOI":"10.1038\/s41598-020-71296-0"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Takahashi A, Arinaga-Hino T, Ohira H, et al. Non-alcoholic fatty liver disease in patients with autoimmune hepatitis. JGH Open 2: 54-58, 2018.","DOI":"10.1002\/jgh3.12046"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. De Luca-Johnson J, Wangensteen KJ, Hanson J, Krawitt E, Wilcox R. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease. Dig Dis Sci 61: 2710-2720, 2016.","DOI":"10.1007\/s10620-016-4213-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Strzepka J, Schwartz BA, Ritz EM, Aloman C, Reau N. Patients with autoimmune hepatitis and nonalcoholic fatty liver disease: characteristics, treatment, and outcomes. J Clin Gastroenterol 58: 91-97, 2024.","DOI":"10.1097\/MCG.0000000000001817"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Al-Omary A, Byth K, Weltman M, George J, Eslam M. The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C. J Dig Dis 23: 33-43, 2022.","DOI":"10.1111\/1751-2980.13071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. van Kleef LA, Choi HSJ, Brouwer WP, et al. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. JHEP Rep 3: 100350, 2021.","DOI":"10.1016\/j.jhepr.2021.100350"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79: 1542-1556, 2023.","DOI":"10.1097\/HEP.0000000000000696"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group: review of criteria of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48: 169-176, 2008.","DOI":"10.1002\/hep.22322"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ohira H, Takahashi A, Zeniya M, et al. Clinical practice guidelines for autoimmune hepatitis. Hepatol Res 52: 571-585, 2022.","DOI":"10.1111\/hepr.13776"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. European Association for the Study of the Liver clinical practice guidelines. autoimmune hepatitis. J Hepatol 63: 971-1004, 2015.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rizvi S, Gawrieh S. Autoimmune hepatitis in the elderly: diagnosis and pharmacologic management. Drugs Aging 35: 589-602, 2018.","DOI":"10.1007\/s40266-018-0556-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takahashi A, Arinaga-Hino T, Ohira H, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol 52: 631-640, 2017.","DOI":"10.1007\/s00535-016-1267-0"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72: 671-722, 2020.","DOI":"10.1002\/hep.31065"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kawaguchi T, Tsutsumi T, Nakano D, Torimura T. MAFLD: renovation of clinical practice and disease awareness of fatty liver. Hepatol Res 52: 422-432, 2022.","DOI":"10.1111\/hepr.13706"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamamura S, Eslam M, Kawaguchi T, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40: 3018-3030, 2020.","DOI":"10.1111\/liv.14675"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int 40: 2082-2089, 2020.","DOI":"10.1111\/liv.14548"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Liu Q, Zhao G, Li Q, Wu W, Zhang Y, Bian H. A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study. BMC Gastroenterol 22: 471, 2022.","DOI":"10.1186\/s12876-022-02576-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3112-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:33:44Z","timestamp":1738380824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3112-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3112-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"article-number":"3112-23"}}